Mental Health Research Grants

Active

Assistance listing
93.242
Agency
Grant awards
33,576 $40,689,151,157 in federal obligations

Program facts

Assistance types
  • Project Grant
  • Cooperative Agreement
  • Block Grant
Treasury account
  • 75-0892-0-1-552
More information

Program details come from SAM.gov Assistance Listings. Updated . Grant award figures come from USAspending.gov.

About this program

The National Institute of Mental Health (NIMH) funds basic and translational research through CFDA 93.242, Mental Health Research Grants, with the most recent award issued on March 1, 2027. Awarded grants span basic neuroscience investigating neural circuits and genetic mechanisms underlying mental disorders, clinical research on psychiatric symptoms and treatment outcomes, and translational work bridging molecular findings to therapeutic interventions. The program is predominantly Project Grants (86% of 28,916 awards), with smaller shares of Cooperative Agreements (10%) and Block Grants (4%). Recent awards from February and March 2027 include projects on structural variants in autism, glutamatergic neuron perturbations across psychiatric disorders, memory-based generalization in humans, and cerebellar contributions to schizophrenia spectrum disorders—all funded as Project Grants ranging from $38,235 to $162,560.

The program concentrates funding heavily within NIMH: the National Institute of Mental Health itself awarded 10,425 grants totaling $28.6 billion in federal dollars obligated (70% of all federal dollars), while the broader NIH organization awarded 22,253 grants totaling $10.84 billion. The Department of Health and Human Services made 806 additional awards worth $967.5 million. Combined federal dollars obligated across all funders total $40.69 billion, with a non-federal cost-share component bringing total obligated dollars to $42.53 billion. Recent grant activity shows a cadence of approximately 500–900 awards annually (2023: 888; 2024: 853; 2025: 433; 2026: 561), with grant awards continuous since 1972. Applications are evaluated on scientific and technical merit by peer review panels and compete for funding based on scientific merit, program relevance, and program balance. Typical award durations are up to 5 years for renewal-eligible Project Grants; some fellowship (F30, F31, F32) and career development (K) awards have term limits of 1–5 years without renewal. Several grant opportunities are currently open or recently posted: RFA-MH-27-150 on rapid-acting psychotropic interventional drugs closed posting September 2026; RFA-MH-28-110 on BRAIN Initiative tool development was posted June 2026; and PAR-27-127 on Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research remains open with a due date of May 25, 2028.

Objective and description

Objective

The mission of the National Institute of Mental Health (NIMH) is to transform the understanding and treatment of mental illnesses through basic and clinical research, paving the way for prevention, recovery, and cure. We fulfill this mission

Description

The mission of the National Institute of Mental Health (NIMH) is to transform the understanding and treatment of mental illnesses through basic and clinical research, paving the way for prevention, recovery, and cure.

Eligibility

Applicant eligibility

Public, private, -profit, or nonprofit agencies (including State and local government agencies), eligible Federal agencies, universities, colleges, hospitals, and academic or research institutions may apply for research grants. SBIR grants can be awarded only to domestic small businesses, and STTR grants can be awarded only to domestic small businesses which "partner" with a research institution in cooperative research and development. An applicant for individual predoctoral fellowship support must be enrolled in a research doctoral degree program by the proposed activation date of the fellowship. A postdoctoral applicant must have received a Ph.D., Psy.D., M.D., D.D.S., Sc.D., D.N.S., D.O., D.S.W., or equivalent degree from an accredited institution to be eligible for an individual postdoctoral fellowship. All research training awards are made to appropriate domestic research centers, medical schools, departments of psychiatry, non-medical academic departments, psychiatric hospitals or hospitals with psychiatric services, community mental health centers, and biomedical research institutes on behalf of individuals who need the opportunity to realize research potential. Except for the NIH Pathway to Independence (PI) Award (K99/R00), the individuals must be citizens or nationals of the United States or have been lawfully admitted for permanent residence. The NIH Pathway to Independence (PI) Award (K99/R00) is open to both U.S. citizens and non-U.S. citizens. Individuals must qualify by scholastic degree and previous training and/or experience.

Beneficiary eligibility

Individuals and public, private, profit, or nonprofit organizations.

Uses of assistance

Research project grants provide support for clearly defined projects by a named investigator in an area representing his/her specific interests and competencies. Exploratory/Development and Clinical Exploratory/Developmental Grants encourage the development of new research activities in categorical program areas. Small Research Grants provide research support specifically limited in time and amount for studies in categorical program areas. Collaborative Clinical Research Grants support evaluations of various methods of therapy and/or prevention. Program Project and Center grants support large-scale, broad-based programs of research, usually interdisciplinary, consisting of several projects with a common focus. Cooperative Agreements support single or a group of related research activities with greater involvement of federal staff. SBIR and STTR grants are awarded in two stages: Phase I grants are awarded to establish the technical merit and feasibility of a proposed research and development effort; only Phase I awardees are eligible to receive Phase II support. Mentored Research Scientist Development Award (K01, MRSDA), Mentored Clinical Scientist Development Award (K08, MCSDA), and Mentored Quantitative Research Career Development Award (K25) provide support for individuals with research potential who need additional mentored development and/or experience in a productive research environment. Mentored Patient-Oriented Research Career Development Award (K23) supports the career development of individuals who have made commitment to focus their research endeavors on patient-oriented research. The NIH Pathway to Independence (PI) Award (K99/R00) provides up to 2 years of mentored support (K99) for a postdoctoral individual followed by up to 3 years of support after the awardee transitions to research independence (R00). K99/R00 awards are awards for up to 5 years of support. Salary support for all mentored awards may be supplemented by the sponsoring institution from nonfederal funds. The Independent Scientist Award (K02, ISA) is for independent scientists whose careers are developing rapidly; the Mid-career Investigator Award in Patient-Oriented Research (K24) is for outstanding clinical scientists engaged in patient-oriented research. No specialized training costs are available; limited research costs for K24s and K02s in theoretical areas are available. NRSA awards: Individual fellowships are made to students seeking predoctoral or postdoctoral support for full-time research training or who are enrolled in an formal Ph.D. or M.D./Ph.D. program. An institutional allowance will be provided to the sponsoring institution for each awardee. In addition, any domestic public or nonprofit institution may apply for an institutional research training grant in a specified area of research from which a number of stipend awards will be made to individuals selected by the training program director at the institution. Support is available for both predoctoral and postdoctoral trainees and will include an amount for institutional expenses. Indirect costs may be requested at 8 percent of total direct costs, exclusive of tuition and related fees and expenditures for equipment, or actual indirect costs, whichever is less. Postdoctoral students receiving fellowships or stipend support under either individual or institutional grants for 12 months or less are obligated to pay back this support through an equivalent period of continued postdoctoral training or a period of health related research and/or teaching activities after the completion of their training. Postdoctoral individuals in their thirteenth and subsequent months of support will incur no further obligation, and such support will be considered acceptable postdoctoral payback service. Research training support may not be used for internships or other clinical training.

Length and time phasing of assistance

Varies, with a project periods ranging from 1 to 5 years. Funding commitments are made annually. See the following for information on how assistance is awarded/released: A formal notification in the form of a Notice of Award (NoA) will be provided to the applicant organization. SBIR: Generally, Phase I awards are for 6 months, and Phase II awards are for 2 years. STTR: Generally, Phase I awards are for 1 year and Phase II awards are for 2 years. Information on how assistance is awarded/released: A formal notification in the form of a Notice of Award (NoA) will be provided to the applicant organization. By law an individual may receive no more than 6 years of support in the aggregate at the predoctoral level and no more than 3 years of support in the aggregate at the postdoctoral level under the NRSA program (through an individual and/or institutional award). For an M.D./Ph.D. fellowship, 6 years may be requested. In practice, recommendations of review committees are generally for 2 or 3 years.

How to apply

Criteria for selecting proposals

The following consideration will be used in determining projects to be funded: (1) Technical merit of the proposed project as determined by peer review; (2) Availability of funds; and (3) Relevance to program priorities.

Award procedure

All applications are evaluated for scientific and technical merit by an appropriate scientific peer review panel. Applications other than fellowships must also be reviewed by the National Advisory Mental Health Council . All competitive applications compete for available funds on the basis of scientific and technical merit, program relevance, and program balance. All SBIR and STTR applications receiving a priority score compete for set-aside funds on the basis of scientific and technical merit and commercial potential of the proposed research, program relevance, and program balance among the areas of research.

Time to approval or disapproval

Applications: From 180 to 270 days from submission of application. SBIR/STTR applications: About 7- 12 months; AIDS-related research is expedited and a determination is made within 180 days.

Renewals

Support is recommended for a specified project period, not in excess of 5 years. Prior to termination of a project period, the grantee may apply for renewal of support for a new project period. An application for renewal is processed as a new competing request. Small grants, exploratory, and dissertation grants are for 1-3 years (depending on program) and are not renewable. By law an individual may receive no more than 6 years of support in the aggregate at the predoctoral level and no more than 3 years of support in the aggregate at the postdoctoral level under the NRSA program (through an individual and/or institutional award). Any exception to these limitations requires a waiver from the Director of the awarding Institute based on review of justification from the awardee and the program director for the institutional grant. K01, K08, K23, K25 awards are made for up to 5-year periods with no renewal. K02 and K24 awards are made for a 5-year period, renewable once (unless holder has held a previous K02 or K24 award). K99 awards are made for up to 2-year periods with no renewal.

Appeals

A principal investigator may question the substantive or procedural aspects of the review of his/her application by communicating with the staff of the Institute. A description of the NIH Peer Review Appeal procedures is available on the NIH homepage http://grants.nih.gov/grants/guide/notice-files/NOT-OD-11-064.html

Grant opportunities

Opportunity Status Posted Applications due
Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) RFA-MH-27-150 Forecasted —
Single Source: Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes: Data Resource and Administrative Coordination Center (U24 Clinical Trial Not Allowed) RFA-MH-28-115 Forecasted —
BRAIN Initiative: Development and Validation of Novel Tools and New Approaches for Neuroscience Research RFA-MH-28-110 Forecasted —
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) PAR-28-033 Forecasted —
Impact of Immunotherapies on CNS Outcomes in People with HIV: Potential Benefits, Challenges and Risks RFA-MH-27-110 Forecasted —
Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers PAR-27-008 Forecasted —
BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE) RFA-MH-27-120 Past —
BRAIN Initiative: Data Archives for the BRAIN Initiative RFA-MH-28-100 Forecasted —
NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) RFA-LM-28-001 Open
Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional) PAR-27-076 Open
NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional) PA-26-002 Open
NIH Research Education Program - Research Experiences (Parent R25 - Clinical Trial Not Allowed) PA-27-036 Open
NIH Research Educational Program - Mentoring Activities & Networks (Parent R25/UE5 - Clinical Trial Not Allowed) PA-27-035 Open
Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional) RFA-AI-27-018 Open
Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed) PAR-28-090 Open
Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed) PAR-27-081 Open
Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R01 Clinical Trial Optional) PAR-27-090 Open
INCLUDE Project: Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed) RFA-OD-27-004 Open
Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional) PAR-27-127 Open
Establishing Pediatric CNS Pharmacodynamic Measures as Tools to Enable Psychiatric Indications in Adolescents PAR-26-049 Past —
NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed) PAR-27-051 Open
BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program - iBCP (RM1 Clinical Trial Not Allowed) RFA-NS-27-002 Open
BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed) RFA-NS-28-010 Open
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) PA-26-001 Open
Limited Competition: Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed) PAR-27-067 Open
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science 25-542 Closed
Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 CT Not Allowed) RFA-HD-27-007 Open
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) PA-27-100 Open
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) PA-27-102 Open
NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional) PA-27-101 Open
Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required) RFA-MH-27-135 Closed
Single Source: Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Data Processing, Analysis, and Coordination Center (DPACC) (U24 Clinical Trial Not Allowed) RFA-MH-27-205 Closed
Advancing Research on Empirically-Supported Interventions for Older Adults Living with Serious Mental Illness (SMI) (R01 Clinical Trial Optional) RFA-MH-27-180 Closed
Pilot Effectiveness Trials of Peer Support Services for Suicide Prevention FOR-MH-26-160 Past —
Research on System Support and Tools for Provider Training and Quality Monitoring for Suicide Preventive Care FOR-MH-26-145 Past —
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) PAR-27-078 Open
NIH Research Education Program - Courses, Curriculum & Methods (Parent R25 - Clinical Trial Not Allowed) PA-27-034 Open
Predoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed) PA-27-037 Open
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional) PAR-27-098 Open
BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed) RFA-DC-27-004 Open
Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed) RFA-MH-27-125 Open
Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed) PAR-25-442 Open
NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed) PAR-27-077 Open
Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required) RFA-MH-27-140 Open
NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01 Clinical Trial Optional) FOR-MH-26-200 Past —
Small Business Translator: MedTech and Digital Health Technologies FOR-NS-25-017 Past —
Implementation and Evaluation of Databases to Examine AIDS RFA-AI-28-025 Forecasted —
BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed) RFA-DA-27-004 Open
Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed) PAR-25-415 Open
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) PAR-25-322 Open
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

Grant awards

Award Recipient Federal obligations Awarded
Illuminating the role of structural variants in the genetic architecture of autism spectrum disorder F31MH141823 President And Fellows Of Harvard College $38,235
Neural correlates of memory-based generalization in humans F30MH144910 University Of California, Davis $43,749
Mapping convergence in autism and schizophrenia: high-throughput characterization of glutamatergic neurons harboring… F30MH142021 University Of California, LOS Angeles $43,058
A computational model linking microcircuit properties to cortex-wide activity during decision making F31MH143476 Northwestern University $45,327
Precision brain mapping of functional hubs across the adult lifespan F32MH142086 University Of Illinois $76,780
Autonomic and neural mechanisms of ruminative brooding and its emotional consequences in daily life in remitted… F31MH146547 University Of Southern California $50,114
Cerebellar gabaergic perturbation in a NDD mouse model F31MH144827 University Of California, Davis $43,749
Functionally specialized temporal and frontal lobe regions for identity recognition and updating F31MH146175 University Of Pittsburgh - Of The Commonwealth System Of Higher Education $50,114
Cytokine modulation of dorsal raphe nucleus neurons underlying depressive-like behavior F31MH146025 Northwestern University $50,114
Characterizing accumbens-pallidum circuits in approach/avoidance conflict F31MH143586 University Of Puerto Rico Medical Sciences Campus $75,428

Latest 10 of 33,576 listed here. See the rest on GovTribe.

Top recipients by federal obligations

10 of 1,220 recipients listed here. See the rest on GovTribe.

Federal obligations by fiscal year

Fiscal year Federal obligations
FY2026 $1,745,478,963
FY2025 $2,826,660,294
FY2024 $3,820,571,690
FY2023 $4,042,939,931
FY2022 $3,789,051,660
FY2021 $3,311,593,545
FY2020 $1,669,523,140
FY2019 $1,571,418,868
FY2018 $1,447,068,125
FY2017 $1,347,475,690
FY2016 $1,223,882,660
FY2015 $1,139,494,507
FY2014 $1,141,593,789
FY2013 $1,106,440,213
FY2012 $1,112,430,301
FY2011 $1,072,908,365
FY2010 $1,130,567,520
FY2009 $1,098,803,035
FY2008 $494,315,588
FY2007 $741,373,682
FY2006 $1,007,104,977
FY2005 $1,042,121,974
FY2004 $903,808,630
FY2003 $870,807,054
FY2002 $822,361,854
FY2001 $367,284,330
Show all 26

Quick answers

What is Assistance Listing 93.242?

Assistance Listing 93.242 is Mental Health Research Grants, a federal grant program run by National Institutes of Health (Department of Health and Human Services).

What is the CFDA number for Mental Health Research Grants?

Its CFDA number is 93.242: Assistance Listing numbers were called CFDA numbers before 2018.

How much funding has Assistance Listing 93.242 awarded?

33,576 grant awards under 93.242 have obligated $40,689,151,157 in federal funds to 1,220 recipients.

Who receives the most funding from 93.242?

The recipients obligated the most under Mental Health Research Grants are Yale Univ ($1,419,729,818), University Of Pittsburgh - Of The Commonwealth System Of Higher Education ($1,201,941,638) and University Of California, LOS Angeles ($1,085,966,881).

How much did 93.242 obligate in fiscal year 2025?

Grants under 93.242 obligated $2,826,660,294 in federal funds in fiscal year 2025.

Are there open grant opportunities under 93.242?

40 of the latest 50 opportunities under 93.242 are open or forecasted. The latest, Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs), was posted on September 16, 2026.

On GovTribe

See this program's full record

  • Every grant award and opportunity under it
  • Funding by recipient, agency and assistance type
  • Alerts for new opportunities
  • Ask GovTribe AI about this program